Treatment Options From 5 Experts for Patients With HER2-Positive Early-Stage Breast Cancer

Were you recently diagnosed with HER2-positive early-stage breast cancer? CCO and GRACE have partnered to develop a Treatment Decision Support Tool to help you understand more about your cancer diagnosis and treatment options. Answer these multiple choice questions to see treatment plans from 5 oncology experts.

Share

Program Content

Activities

HER2+ EBC Consultation Checklist
Online Treatment Tool for Patients: Key Information You Need to Know About Your HER2-Positive Early Breast Cancer Diagnosis
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: March 19, 2019

Expires: March 17, 2020

Activities

Expert Insights on HER2+ EBC
Treatment Options From 5 Experts on Neoadjuvant and Adjuvant Therapy for HER2-Positive Early Breast Cancer: An Online Tool
Tool
Congratulations: You achieved a completion on 04/09/2022

Released: March 19, 2019

Expires: March 17, 2020

Provided by

ProCE Banner

Supporters

This activity is supported by an educational grant from

Genentech TEXT Only

Partners

GRACE

ProCE Banner